{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:32:51Z","timestamp":1791196371976,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Agence Nationale pour la Recherche"},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002738","name":"AP-HP","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fondation Fondamental"}],"content-domain":{"domain":["journalofpsychiatricresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jpsychires.2015.02.011","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T14:53:20Z","timestamp":1424789600000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: A cross-sectional study"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3249-2030","authenticated-orcid":false,"given":"Guillaume","family":"Fond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Gaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Laouamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dodji","family":"Attiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Romain","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Delavest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josselin","family":"Houenou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Le Corvoisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajagopal","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryad","family":"Tamouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2015.02.011_bib1","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.4088\/JCP.13078tx2c","article-title":"Schizophrenia: overview and dopamine dysfunction","volume":"75","author":"Abi-Dargham","year":"2014","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005053-199309000-00006","article-title":"Rating depression in schizophrenia. A comparison of a self-report and an observer report scale","volume":"181","author":"Addington","year":"1993","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib3","first-page":"31","article-title":"Toxoplasma infection in schizophrenia patients: a comparative study with control group","volume":"6","author":"Alipour","year":"2011","journal-title":"Iran J Parasitol"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/NMD.0000000000000037","article-title":"Toxoplasma gondii infection and suicide attempts: a case-control study in psychiatric outpatients","volume":"201","author":"Alvarado-Esquivel","year":"2013","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.schres.2011.10.026","article-title":"Infectious agents associated with schizophrenia: a meta-analysis","volume":"136","author":"Arias","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/schbul\/sbq146","article-title":"Maternal infection and schizophrenia: implications for prevention","volume":"37","author":"Brown","year":"2011","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0001-706X(01)00201-7","article-title":"Host cell invasion by the opportunistic pathogen Toxoplasma gondii","volume":"81","author":"Carruthers","year":"2002","journal-title":"Acta trop"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/475027a","article-title":"Grand challenges in global mental health","volume":"475","author":"Collins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00436-009-1526-6","article-title":"Toxoplasma gondii: host-parasite interaction and behavior manipulation","volume":"105","author":"da Silva","year":"2009","journal-title":"Parasitol Res"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib11","first-page":"151","article-title":"Seroprevalence of anti-Toxoplasma gondii IgG antibody in patients with schizophrenia","volume":"29","author":"Emelia","year":"2012","journal-title":"Trop Biomed"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/mp.2008.148","article-title":"A\u00a0SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain","volume":"15","author":"Etain","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.encep.2012.06.014","article-title":"Toxoplasma gondii: a potential role in the genesis of psychiatric disorders","volume":"39","author":"Fond","year":"2013","journal-title":"Encephale"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/acps.12211","article-title":"Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review","volume":"129","author":"Fond","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00406-013-0413-4","article-title":"Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate","volume":"264","author":"Fond","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/070674371305800410","article-title":"Early onset bipolar disorder: validation from admixture analyses and biomarkers","volume":"58","author":"Geoffroy","year":"2013","journal-title":"Can J Psychiatry Revue Can de Psychiatrie"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1645\/GE-2536.1","article-title":"Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures","volume":"97","author":"Goodwin","year":"2011","journal-title":"J\u00a0Parasitol"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2012.11.034","article-title":"Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample","author":"Hamdani","year":"2013","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/schbul\/sbm010","article-title":"A\u00a0controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence","volume":"33","author":"Hinze-Selch","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib20","doi-asserted-by":"crossref","first-page":"e104326","DOI":"10.1371\/journal.pone.0104326","article-title":"Common and rare variant analysis in early-onset bipolar disorder vulnerability","volume":"9","author":"Jamain","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","article-title":"Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii","volume":"62","author":"Jones-Brando","year":"2003","journal-title":"Schizophrenia Res"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib23","first-page":"79","article-title":"The positive-negative dimension in schizophrenia: its validity and significance","volume":"5","author":"Kay","year":"1987","journal-title":"Psychiatr Dev"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib24","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.micinf.2008.07.015","article-title":"Toxoplasma: the next 100years","volume":"10","author":"Kim","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib25","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/ajmg.b.31121","article-title":"European collaborative study of early-onset bipolar disorder: evidence for genetic heterogeneity on 2q14 according to age at onset","volume":"153B","author":"Mathieu","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A\u00a0new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2012.08.036","article-title":"Prevalence of antibodies to Toxoplasma gondii in patients with schizophrenia and mood disorders","author":"Nascimento","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib28","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1017\/S0950268813002756","article-title":"Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation","volume":"142","author":"Nogareda","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2011.08.006","article-title":"Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia","volume":"133","author":"Okusaga","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib30","series-title":"The neurobiological basis of suicide","article-title":"Toxoplasma gondii, the immune System, and suicidal behavior","author":"Okusaga","year":"2012"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.biopsych.2012.01.003","article-title":"The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey","volume":"72","author":"Pearce","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib33","doi-asserted-by":"crossref","first-page":"e23866","DOI":"10.1371\/journal.pone.0023866","article-title":"The neurotropic parasite Toxoplasma gondii increases dopamine metabolism","volume":"6","author":"Prandovszky","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0033-1363258","article-title":"Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics","volume":"47","author":"Selle","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/schbul\/sbn191","article-title":"Trimethoprim as adjuvant treatment in schizophrenia: a double-blind, randomized, placebo-controlled clinical trial","volume":"36","author":"Shibre","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib37","first-page":"211","article-title":"Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study","volume":"49","author":"Tedla","year":"2011","journal-title":"Ethiop Med J"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbl050","article-title":"Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis","volume":"33","author":"Torrey","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/schbul\/sbs043","article-title":"Toxoplasma gondii and other risk factors for schizophrenia: an update","volume":"38","author":"Torrey","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3371\/CSRP.5.4.5","article-title":"Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas","volume":"5","author":"Torrey","year":"2012","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0447.2006.00780.x","article-title":"Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia","volume":"114","author":"Wang","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib42","article-title":"Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by Toxoplasma gondii on host dopamine levels","author":"Wang","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib43","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1098\/rspb.2005.3413","article-title":"Parasites as causative agents of human affective disorders? the impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour","volume":"273","author":"Webster","year":"2006","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib44","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/319221","article-title":"Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia","volume":"32","author":"Yolken","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-3024.2009.01131.x","article-title":"Fuller torrey e. Toxoplasma and schizophrenia","volume":"31","author":"Yolken","year":"2009","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.jpsychires.2015.02.011_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A\u00a0rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry J Ment Sci"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T02:35:39Z","timestamp":1566354939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395615000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":46,"alternative-id":["S0022395615000436"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.02.011","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}